Inventor · disambiguated record
Tetsuji Yamaoka
Also filed as: YAMAOKA TETSUJI
7 granted patents·3 pending applications·3 citations·filing 2002–2018
70Inventor score
Top patents by PatentIndex Score
10 records- 0169US9127280B2Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredientOBIKA SATOSHI·Filed 2011·Granted Sep 8, 2015·3 cites·10 claims
- 0255US10351600B2Peptide and complex of same, scaffold for tissue repair and surface treatment method for same, and surface treatment solution or set of treatment solutionsNAT CEREBRAL & CARDIOVASCULAR CT·Filed 2017·Granted Jul 16, 2019·0 cites·8 claims
- 0353US7550512B2Medical polymers and uses thereofUNIV KEIO·Filed 2004·Granted Jun 23, 2009·0 cites·3 claims
- 0452US2016137694A1Peptide and Complex of Same, Scaffold for Tissue Repair and Surface Treatment Method for Same, and Surface Treatment Solution or Set of Treatment SolutionsNAT CEREBRAL & CARDIOVASCULAR CT·Filed 2014·Application pending·0 cites
- 0549US2007059828A1Carrier for nucleic acid molecule deliveryYAMAOKA TETSUJI·Filed 2004·Application pending·0 cites
- 0647US8871242B2Blood anticoagulant material, coating material and indwelling device comprising the same, and treatment using blood anticoagulant materialYAMAOKA TETSUJI·Filed 2007·Granted Oct 28, 2014·0 cites·19 claims
- 0746US8834887B2Drug for suppressing pathogen occurring in vivoYAMAOKA TETSUJI·Filed 2008·Granted Sep 16, 2014·0 cites·8 claims
- 0845US9642695B2Artificial blood vessel, and method for producing artificial blood vesselJMS CO LTD·Filed 2013·Granted May 9, 2017·0 cites·15 claims
- 0937US11253626B2Use for peptide uniquely binding to vascular endothelial cells, and peptideNAT CEREBRAL & CARDIOVASCULAR CT·Filed 2018·Granted Feb 22, 2022·0 cites·4 claims
- 1036US2004097659A1Medical polymers and uses thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tetsuji Yamaoka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →